SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-13-001704
Filing Date
2013-02-26
Accepted
2013-02-26 16:17:32
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2213116z10-k.htm 10-K 1184160
2 EX-23.1 a2213116zex-23_1.htm EX-23.1 3380
3 EX-31.1 a2213116zex-31_1.htm EX-31.1 8060
4 EX-31.2 a2213116zex-31_2.htm EX-31.2 8072
5 EX-32 a2213116zex-32.htm EX-32 8876
12 G837546.JPG g837546.jpg GRAPHIC 67972
13 G652533.JPG g652533.jpg GRAPHIC 57156
  Complete submission text file 0001047469-13-001704.txt   9885922

Data Files

Seq Description Document Type Size
6 EX-101.INS thrx-20121231.xml EX-101.INS 1285977
7 EX-101.SCH thrx-20121231.xsd EX-101.SCH 86544
8 EX-101.CAL thrx-20121231_cal.xml EX-101.CAL 82059
9 EX-101.LAB thrx-20121231_lab.xml EX-101.LAB 1457495
10 EX-101.PRE thrx-20121231_pre.xml EX-101.PRE 660710
11 EX-101.DEF thrx-20121231_def.xml EX-101.DEF 463027
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 13642902
SIC: 2834 Pharmaceutical Preparations